In Part 2 of the 340B for Covered Entities and Manufacturers Webinar Larry Crowder, Director of Cervey and Ambre Ayoub, 340B pharmacy compliance analyst with Seattle Children's Hospital are going to cover the first of five 340B reports, the WAC Impact Report (DSH/PED). These five reports are to ensure compliance, maximize savings in the 340B program.
Missed part 1? You can find more info on the NDC or Code Mismatch Report here.
This post is related to:
340B Solutions, 340B Management Systems
